NCT03518138 2021-07-23
Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor
Que Oncology
Phase 2 Completed
Clinical Trials
3 trialsNCT04080297 2020-02-28
Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen
Que Oncology
Phase 1 Completed
NCT00591682 2008-03-26
MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
Metastatix, Inc.
Phase 1 Suspended